HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 7, 4894-4900, February 16, 2001

This Article Full Text Full Text (PDF) All Versions of this Article: 276/7/4894    most recent M007437200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Celver, J. P. Articles by Chavkin, C. Search for Related Content PubMed PubMed Citation Articles by Celver, J. P. Articles by Chavkin, C. Social Bookmarking                      What's this?

Threonine 180 Is Required for G-protein-coupled Receptor Kinase 3- and -Arrestin 2-mediated Desensitization of the µ-Opioid Receptor in Xenopus Oocytes^*

Jeremy P. Celver, Janet Lowe, Abraham Kovoor^§, Vsevolod V. Gurevich^¶, and Charles Chavkin

From the  Department of Pharmacology, University of Washington, Seattle, Washington 98195-7280 and the ^¶ Ralph and Muriel Roberts Laboratory for Vision Science, Sun Health Research Institute, Sun City, Arizona 85351

To determine the sites in the µ-opioid receptor (MOR) critical for agonist-dependent desensitization, we constructed and coexpressed MORs lacking potential phosphorylation sites along with G-protein activated inwardly rectifying potassium channels composed of K_ir3.1 and K_ir3.4 subunits in Xenopus oocytes. Activation of MOR by the stable enkephalin analogue, [D-Ala²,MePhe⁴,Glyol⁵]enkephalin, led to homologous MOR desensitization in oocytes coexpressing both G-protein-coupled receptor kinase 3 (GRK3) and -arrestin 2 (arr3). Coexpression with either GRK3 or arr3 individually did not significantly enhance desensitization of responses evoked by wild type MOR activation. Mutation of serine or threonine residues to alanines in the putative third cytoplasmic loop and truncation of the C-terminal tail did not block GRK/arr3-mediated desensitization of MOR. Instead, alanine substitution of a single threonine in the second cytoplasmic loop to produce MOR(T180A) was sufficient to block homologous desensitization. The insensitivity of MOR(T180A) might have resulted either from a block of arrestin activation or arrestin binding to MOR. To distinguish between these alternatives, we expressed a dominant positive arrestin, arr2(R169E), that desensitizes G protein-coupled receptors in an agonist-dependent but phosphorylation-independent manner. arr2(R169E) produced robust desensitization of MOR and MOR(T180A) in the absence of GRK3 coexpression. These results demonstrate that the T180A mutation probably blocks GRK3- and arr3-mediated desensitization of MOR by preventing a critical agonist-dependent receptor phosphorylation and suggest a novel GRK3 site of regulation not yet described for other G-protein-coupled receptors.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y. Qiu, H. H. Loh, and P.-Y. Law Phosphorylation of the {delta}-Opioid Receptor Regulates Its beta-Arrestins Selectivity and Subsequent Receptor Internalization and Adenylyl Cyclase Desensitization J. Biol. Chem., August 3, 2007; 282(31): 22315 - 22323. [Abstract] [Full Text] [PDF]

				C. E. Groer, K. Tidgewell, R. A. Moyer, W. W. Harding, R. B. Rothman, T. E. Prisinzano, and L. M. Bohn An Opioid Agonist that Does Not Induce {micro}-Opioid Receptor--Arrestin Interactions or Receptor Internalization Mol. Pharmacol., February 1, 2007; 71(2): 549 - 557. [Abstract] [Full Text] [PDF]

				E. A. Johnson, S. Oldfield, E. Braksator, A. Gonzalez-Cuello, D. Couch, K. J. Hall, S. J. Mundell, C. P. Bailey, E. Kelly, and G. Henderson Agonist-Selective Mechanisms of {micro}-Opioid Receptor Desensitization in Human Embryonic Kidney 293 Cells Mol. Pharmacol., August 1, 2006; 70(2): 676 - 685. [Abstract] [Full Text] [PDF]

				S. Marion, R. H. Oakley, K.-M. Kim, M. G. Caron, and L. S. Barak A beta-Arrestin Binding Determinant Common to the Second Intracellular Loops of Rhodopsin Family G Protein-coupled Receptors J. Biol. Chem., February 3, 2006; 281(5): 2932 - 2938. [Abstract] [Full Text] [PDF]

				D. M. Kenski, C. Zhang, M. von Zastrow, and K. M. Shokat Chemical Genetic Engineering of G Protein-coupled Receptor Kinase 2 J. Biol. Chem., October 14, 2005; 280(41): 35051 - 35061. [Abstract] [Full Text] [PDF]

				R. T. Venkatesha, J. Ahamed, C. Nuesch, A. K. Zaidi, and H. Ali Platelet-activating Factor-induced Chemokine Gene Expression Requires NF-{kappa}B Activation and Ca2+/Calcineurin Signaling Pathways: INHIBITION BY RECEPTOR PHOSPHORYLATION AND {beta}-ARRESTIN RECRUITMENT J. Biol. Chem., October 22, 2004; 279(43): 44606 - 44612. [Abstract] [Full Text] [PDF]

				B. M. Cox and A. T. Crowder Receptor Domains Regulating {micro} Opioid Receptor Uncoupling and Internalization: Relevance to Opioid Tolerance Mol. Pharmacol., March 1, 2004; 65(3): 492 - 495. [Full Text] [PDF]

				J. Celver, M. Xu, W. Jin, J. Lowe, and C. Chavkin Distinct Domains of the {micro}-Opioid Receptor Control Uncoupling and Internalization Mol. Pharmacol., March 1, 2004; 65(3): 528 - 537. [Abstract] [Full Text] [PDF]

				Y. Qiu, P.-Y. Law, and H. H. Loh {micro}-Opioid Receptor Desensitization: ROLE OF RECEPTOR PHOSPHORYLATION, INTERNALIZATION, AND RESENSITIZATION J. Biol. Chem., September 19, 2003; 278(38): 36733 - 36739. [Abstract] [Full Text] [PDF]

				J. P. McLaughlin, M. Xu, K. Mackie, and C. Chavkin Phosphorylation of a Carboxyl-terminal Serine within the {kappa}-Opioid Receptor Produces Desensitization and Internalization J. Biol. Chem., September 5, 2003; 278(36): 34631 - 34640. [Abstract] [Full Text] [PDF]

				C. D. Mandyam, D. R. Thakker, and K. M. Standifer {micro}-Opioid-Induced Desensitization of Opioid Receptor-Like 1 and {micro}-Opioid Receptors: Differential Intracellular Signaling Determines Receptor Sensitivity J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 965 - 972. [Abstract] [Full Text] [PDF]

				S. L. Borgland, M. Connor, P. B. Osborne, J. B. Furness, and M. J. Christie Opioid Agonists Have Different Efficacy Profiles for G Protein Activation, Rapid Desensitization, and Endocytosis of Mu-opioid Receptors J. Biol. Chem., May 23, 2003; 278(21): 18776 - 18784. [Abstract] [Full Text] [PDF]

				C. D. Mandyam, D. R. Thakker, J. L. Christensen, and K. M. Standifer Orphanin FQ/Nociceptin-Mediated Desensitization of Opioid Receptor-Like 1 Receptor and {micro} Opioid Receptors Involves Protein Kinase C: A Molecular Mechanism for Heterologous Cross-Talk J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 502 - 509. [Abstract] [Full Text] [PDF]

				R. Schulz, A. Wehmeyer, and K. Schulz Visualizing Preference of G Protein-Coupled Receptor Kinase 3 for the Process of kappa -Opioid Receptor Sequestration Mol. Pharmacol., June 1, 2002; 61(6): 1444 - 1452. [Abstract] [Full Text] [PDF]

				J. D. Lowe, J. P. Celver, V. V. Gurevich, and C. Chavkin {micro}-Opioid Receptors Desensitize Less Rapidly than delta -Opioid Receptors Due to Less Efficient Activation of Arrestin J. Biol. Chem., May 3, 2002; 277(18): 15729 - 15735. [Abstract] [Full Text] [PDF]

				R. M. Potter, T. A. Key, V. V. Gurevich, L. A. Sklar, and E. R. Prossnitz Arrestin Variants Display Differential Binding Characteristics for the Phosphorylated N-Formyl Peptide Receptor Carboxyl Terminus J. Biol. Chem., March 8, 2002; 277(11): 8970 - 8978. [Abstract] [Full Text] [PDF]

				C. Chavkin, J. P. McLaughlin, and J. P. Celver Regulation of Opioid Receptor Function by Chronic Agonist Exposure: Constitutive Activity and Desensitization Mol. Pharmacol., July 1, 2001; 60(1): 20 - 25. [Full Text]

				J. P. McLaughlin and C. Chavkin Tyrosine Phosphorylation of the {micro}-Opioid Receptor Regulates Agonist Intrinsic Efficacy Mol. Pharmacol., June 1, 2001; 59(6): 1360 - 1368. [Abstract] [Full Text]